This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Measure of benefits used in the economic analysis
The measure of benefit used was the quality-adjusted life-years (QALYs). The change in the HRQOL score, as measured by the 15D questionnaire, was evaluated. Quality of life data were collected before the operations and 3 months afterwards. The benefits were assumed to last until the end of the patient's statistical life expectancy. A discount rate of 5% was used.
Direct costs
The direct costs used in the analysis were those of the hospital. They were not broken down into components but included both inpatient and outpatient costs. The costs evaluated were those of the treatment, so costs incurred with no treatment were assumed to be zero. The source of the cost data was a database that routinely stores treatment costs of individual patients. The costs were not discounted and the time over which the costs were collated was not stated, although the timeframe might have been similar to that for the collection of quality of life data. The price year was not reported. The resource quantities and the costs were not reported separately.
